265 related articles for article (PubMed ID: 24594994)
1. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
3. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.
Uchida H; Yamazaki K; Fukuma M; Yamada T; Hayashida T; Hasegawa H; Kitajima M; Kitagawa Y; Sakamoto M
Cancer Sci; 2010 Jul; 101(7):1731-7. PubMed ID: 20384634
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in gastric cancer.
Yamanoi K; Fukuma M; Uchida H; Kushima R; Yamazaki K; Katai H; Kanai Y; Sakamoto M
Pathol Int; 2013 Jan; 63(1):13-9. PubMed ID: 23356221
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma.
Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX
Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer.
Xi HQ; Cui JX; Shen WS; Wu XS; Bian SB; Li JY; Song Z; Wei B; Chen L
Oncol Rep; 2014 Jul; 32(1):181-8. PubMed ID: 24859092
[TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated inhibition of Lgr5 leads to decreased angiogenesis in gastric cancer.
Xi HQ; Zhang KC; Li JY; Cui JX; Gao YH; Wei B; Huang D; Chen L
Oncotarget; 2017 May; 8(19):31581-31591. PubMed ID: 28404940
[TBL] [Abstract][Full Text] [Related]
9. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
Wu XS; Xi HQ; Chen L
World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
[TBL] [Abstract][Full Text] [Related]
10. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract][Full Text] [Related]
11. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis.
Huang T; Qiu X; Xiao J; Wang Q; Wang Y; Zhang Y; Bai D
Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):246-53. PubMed ID: 26387842
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Musashi-1, Lgr5, and pEGFR expressions in human small intestinal adenocarcinomas.
Wang Y; Jiang CQ; Fan LF
Tumour Biol; 2015 Aug; 36(8):6075-82. PubMed ID: 25773390
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
[TBL] [Abstract][Full Text] [Related]
15. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.
Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC
J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM
Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983
[TBL] [Abstract][Full Text] [Related]
17. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
Kang XL; He LR; Chen YL; Wang SB
World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
[TBL] [Abstract][Full Text] [Related]
18. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
Hou MF; Chen PM; Chu PY
BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
[TBL] [Abstract][Full Text] [Related]
19. Distribution of Lgr5-positive cancer cells in intramucosal gastric signet-ring cell carcinoma.
Nakajima T; Uehara T; Maruyama Y; Iwaya M; Kobayashi Y; Ota H
Pathol Int; 2016 Sep; 66(9):518-23. PubMed ID: 27593551
[TBL] [Abstract][Full Text] [Related]
20. Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma.
Kuraishi Y; Uehara T; Kobayashi Y; Nakajima T; Watanabe T; Shimizu A; Ota H; Tanaka E
Pathol Res Pract; 2019 Nov; 215(11):152623. PubMed ID: 31543221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
